May 14 (Reuters)-
Immuno Biological Laboratories Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2020 Mar 31, 2019 Mar 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 500 mln 630 mln
(-20.7 pct) (-2.0 pct)
Operating loss 516 mln loss 180 mln
Recurring loss 503 mln loss 159 mln
Net loss 547 mln loss 179 mln
EPS loss 62.24 yen loss 21.21 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T